Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaron Ilan

Showing results (191-200 of 221) with videos related to

Pageof 23
Sort By:
The American Journal of Pathology|February 28, 2009
Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2Gadi Lalazar, Ami Ben Ya'acov, Dan M Livovsky, et al.
Journal of Lipid Research|May 16, 2008
Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trappingGadi Lalazar, Ami Ben Ya'acov, Noa Eliakim-Raz, et al.
Journal of Immunological Methods|April 11, 2017
An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapyEinat Almon, Tawfik Khoury, Ariel Drori, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 6, 2008
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver diseaseYosefa Avraham, Iddo Magen, Olga Zolotarev, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2010
Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob miceYaron Ilan, Ruth Maron, Ann-Marcia Tukpah, et al.
Vaccine|April 22, 2008
Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccinationMeir Mizrahi, Gadi Lalazar, Ami Ben Ya'acov, et al.
Inflammation|January 19, 2023
Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic InflammationAriel Kenig, Tal Keidar-Haran, Henny Azmanov, et al.
Acta Biomaterialia|March 11, 2014
Reduced liver cell death using an alginate scaffold bandage: a novel approach for liver reconstruction after extended partial hepatectomyEyal Shteyer, Ami Ben Ya'acov, Lidia Zolotaryova, et al.
The American Journal of Gastroenterology|March 18, 2006
A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approachMaya Margalit, Eran Israeli, Oren Shibolet, et al.
Gastro Hep Advances|August 12, 2024
Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical TrialYuval Ishay, Joel Neutel, Yotam Kolben, et al.
Pageof 23

Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
The American Journal of Pathology|February 28, 2009
Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2Gadi Lalazar, Ami Ben Ya'acov, Dan M Livovsky, et al.
Journal of Lipid Research|May 16, 2008
Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trappingGadi Lalazar, Ami Ben Ya'acov, Noa Eliakim-Raz, et al.
Journal of Immunological Methods|April 11, 2017
An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapyEinat Almon, Tawfik Khoury, Ariel Drori, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 6, 2008
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver diseaseYosefa Avraham, Iddo Magen, Olga Zolotarev, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2010
Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob miceYaron Ilan, Ruth Maron, Ann-Marcia Tukpah, et al.
Vaccine|April 22, 2008
Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccinationMeir Mizrahi, Gadi Lalazar, Ami Ben Ya'acov, et al.
Inflammation|January 19, 2023
Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic InflammationAriel Kenig, Tal Keidar-Haran, Henny Azmanov, et al.
Acta Biomaterialia|March 11, 2014
Reduced liver cell death using an alginate scaffold bandage: a novel approach for liver reconstruction after extended partial hepatectomyEyal Shteyer, Ami Ben Ya'acov, Lidia Zolotaryova, et al.
The American Journal of Gastroenterology|March 18, 2006
A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approachMaya Margalit, Eran Israeli, Oren Shibolet, et al.
Gastro Hep Advances|August 12, 2024
Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical TrialYuval Ishay, Joel Neutel, Yotam Kolben, et al.
Pageof 23